October 23, 2017
Article in CAP Today about liquid biopsy and the opportunity that tests like Biodesix's Genestrat offer to lung cancer treatment
May 21, 2015
Genestrat: a targeted liquid biopsy for patients with NSCLC. Blood test with 72 hour turnaround time.
A leading data-driven diagnostic solutions company helping answer critical clinical questions faced by physicians, researchers, and biopharmaceutical companies, with a primary focus in lung disease.
2970 Wilderness Place, Suite 100 Boulder, CO 80301
© Copyright 2021 Biodesix. All Rights Reserved.